跳至主要内容
临床试验/NCT00236522
NCT00236522已完成3 期

A Multicenter, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Levofloxacin 750 mg Once Daily for 5 Days Versus Levofloxacin 500 mg Once Daily for 10 Days in the Treatment of Acute Bacterial Sinusitis in Adults.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.0 个研究点目标入组 784 人开始时间: 2002年10月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
784
主要终点
Clinical success (resolution of patient signs and symptoms) at the post-therapy visit.

研究概览

简要总结

The purpose of this study is to evaluate the effectiveness and safety of two antibiotic regimens in the treatment of acute bacterial sinusitis (sinus infection) in non-hospitalized adult patients. A 5-day course of 750 milligrams of levofloxacin given by mouth once daily will be compared to a 10-day course of 500 milligrams of levofloxacin given by mouth once daily.

详细描述

When treating sinus infections (sinusitis) caused by bacteria, the traditional duration of therapy is between 10 and 14 days. In this randomized, double-blind study, 5 days of 750 milligrams of levofloxacin given once daily will be compared to 10 days of 500 milligrams of levofloxacin in the treatment of non-hospitalized adult patients who have acute bacterial sinusitis. To prevent the study doctor, study staff and patients from knowing which study drug they are taking, all study drug will manufactured to look the same and patients on the 5-day regimen will be given placebo for the last 5 days of their participation in the study. Patients will have a sinus specimen collected at the first visit. Safety evaluations will be conducted. The objective of the study is to demonstrate that, in the treatment of acute bacterial sinus infections, a 5-day course of 750 milligrams of levofloxacin given once daily is at least as effective as a 10-day course of 500 milligrams of levofloxacin given once daily and is well tolerated.

Patients will take by mouth 750 milligrams levofloxacin capsules once daily for 5 days followed by placebo capsules once daily for 5 days, or 500 milligrams levofloxacin capsules once daily for 10 days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of acute bacterial sinusitis, defined by clinical signs and symptoms lasting for less than 28 days and the presence of visible nasal infection, and confirmed by computed tomography (CT) or standard sinus x-rays
  • Two or fewer episodes of bacterial sinusitis within the preceding 12 months
  • Willing to undergo maxillary sinus puncture or endoscopy

排除标准

  • Chronic sinusitis
  • Use of systemic antibiotics within the past 72 hours
  • Presence or history of serious complications of sinusitis
  • Surgery for treating sinusitis
  • Required daily use of more than 20 milligrams of prednisone (oral steroid)
  • Cystic fibrosis

结局指标

主要结局

Clinical success (resolution of patient signs and symptoms) at the post-therapy visit.

次要结局

  • Microbiologic response at the post-therapy visit and safety evaluations.

研究者

相似试验

A Comparison of the Safety and Efficacy of Two... | 临床试验